Isopogen has an agile team with world-class expertise in the operations, clinical development and commercialisation of cellular therapies, complemented by international corporate strategy and financial accumen.
CHIEF EXECUTIVE OFFICER/CHIEF SCIENTIFIC OFFICER
Dr Marian Sturm – FFSc (RCPA), PhD, MSc, BSc Hons
An expert in the research, operational and clinical development of cellular treatments, Dr Sturm currently holds the roles of Facility Director of Royal Perth Hospital’s Cell & Tissue Therapies WA (CTTWA), Member of the TGA Advisory Committee on Biologicals & Senior Research Fellow with the Centre for Cell Therapy & Regenerative Medicine, School of Biomedical Sciences, UWA.
CHIEF FINANCIAL OFFICER
PAUL FRY – CA, FCA
Mr Fry was a Partner at Ernst and Young and PricewaterhouseCoopers in Australia and Canada, and consults to companies in a broad range of industries.
OPERATIONS & REGULATORY
JENNIFER POSTMA – BSc, PG Cert (Reg Sc)
Jennifer has over 20 years experience in the manufacture of cell therapies, including the development and commercialisation of spray-on skin and StemSmart™. She is currently the Scientist in-Charge at Royal Perth Hospital Cell & Tissue Therapies WA for MSC manufacture.